Monoamine modulators vs placebo
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
Monoamine modulators showed no clear difference in leaving the study early: for any reason compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes onlyRR 1.05 [0.56, 1.94]3 studies · 115 participantsLow